Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences, Inc.    GILD

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about GILEAD SCIENCES, INC.
09/17GILEAD SCIENCES : to acquire Immunomedics for $21 billion
AQ
09/16GILEAD SCIENCES : Magrolimab an Investigational Anti-CD47 Monoclonal Antibody, R..
AQ
09/15Tech, healthcare mega deals boost virus-stricken M&A market
RE
09/15GILEAD SCIENCES : Magrolimab Gets FDA Breakthrough Therapy Designation in Myelod..
DJ
09/15GILEAD SCIENCES : Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, ..
BU
09/15Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/14GILEAD SCIENCES : COVID SCIENCE-Flu outbreaks may be linked to COVID-19; arthrit..
RE
09/14Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/14Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study
RE
09/14Gilead's shares rise after $21 billion deal for Immunomedics
RE
09/14GILEAD SCIENCES : to Acquire Immunomedics
AQ
09/14GILEAD SCIENCES : Immunomedics Shares More Than Double After Gilead Deal
DJ
09/14GILEAD SCIENCES : Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-..
RE
09/14Gilead bolsters cancer portfolio with $21 bln acquisition of Immunomedics
RE
09/14Gilead Acquires Cancer-Drug Maker -- WSJ
DJ
More most relevant news
All news about GILEAD SCIENCES, INC.
09/17GILEAD SCIENCES : to acquire Immunomedics for $21 billion
AQ
09/16GILEAD SCIENCES : Magrolimab an Investigational Anti-CD47 Monoclonal Antibody, R..
AQ
09/15Tech, healthcare mega deals boost virus-stricken M&A market
RE
09/15GILEAD SCIENCES : Magrolimab Gets FDA Breakthrough Therapy Designation in Myelod..
DJ
09/15GILEAD SCIENCES : Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, ..
BU
09/15Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/15Tech Stocks Lead Index Rebound -- WSJ
DJ
09/15Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/14Deal-making, vaccine hopes spark stock rally
RE
09/14Stock Benchmarks Close Higher to Start the Week
DJ
More news
News in other languages on GILEAD SCIENCES, INC.
09/15USA: Les valeurs à suivre à Wall Street
09/15Près de 2.000 milliards de dollars de fusions-acquisitions cette année, la te..
09/15La fièvre acheteuse
09/14Aktien New York Schluss: Übernahmen bescheren starken Wochenauftakt
09/14Wall Street profite du rebond de la tech
09/14Bourse Zurich: petite progression en entame de semaine
09/14WALL STREET STOCK EXCHANGE : L'Europe finit dans le désordre malgré la hausse de..
09/14Wall Street débute en hausse, la tech tente un rebond
09/14Aktien New York: Übernahme-Welle sorgt für einen starken Wochenauftakt
09/14Wall Street applaudit les nouvelles sur les vaccins et les M&A
Analyst Recommendations on GILEAD SCIENCES, INC.
06/15GILEAD SCIENCES : DZ Bank reaffirms its Buy rating
MD
More recommendations
Press releases
09/17GILEAD SCIENCES : to acquire Immunomedics for $21 billion
AQ
09/16GILEAD SCIENCES : Magrolimab an Investigational Anti-CD47 Monoclonal Antibody, R..
AQ
09/15GILEAD SCIENCES : Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, ..
BU
09/14IMMUNOMEDICS : Wall Street posts solid gains after surge in corporate deals
AQ
09/14GILEAD SCIENCES : to Acquire Immunomedics
AQ
More press releases
Official Publications
08/14Report 
08/14Report 
08/14Report 
08/14Report 
07/30Press Release 
07/30Half-year results 
Upcoming event on GILEAD SCIENCES, INC.